The Analytical Technologies Segment posted revenues of $1.16 billion for the quarter as analytical instruments and the company's clinical diagnostics business saw strong growth over 2009.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.